PARIS, Nov 23 Reuters French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro 2.3 billion investment by Danish pharmaceutical company Novo Nordisk in France, his office said, pitching it as a sign of newly restored French industrial competitiveness.

The investment, for which no detail was provided by Macron39;s office, will be based in Chartres, west of Paris, where Novo already employs nearly 2,000 people. Novo is known for its hugely popular antiobesity drug Wegovy.

The Elysee palace deemed it the most significant investment in the health sector of Macron39;s mandates so far and said it would create 500 jobs.

1 0.9168 euros

Reporting by Michel Rose, Editing by Dominique Vidalon

Source Reuters